Current Treatment Options in Psychiatry最新文献_第10页

Treatment of Sleep Comorbidities in Posttraumatic Stress Disorder. 创伤后应激障碍睡眠合并症的治疗。

Current Treatment Options in Psychiatry Pub Date : 2020-09-01 Epub Date: 2020-06-12 DOI: 10.1007/s40501-020-00222-y

Janeese A Brownlow, Katherine E Miller, Philip R Gehrman

{"title":"Treatment of Sleep Comorbidities in Posttraumatic Stress Disorder.","authors":"Janeese A Brownlow, Katherine E Miller, Philip R Gehrman","doi":"10.1007/s40501-020-00222-y","DOIUrl":"https://doi.org/10.1007/s40501-020-00222-y","url":null,"abstract":"Purpose of the review: Sleep disturbances, insomnia and recurrent nightmares in particular, are among the most frequently endorsed symptoms of posttraumatic stress disorder (PTSD). The present review provides a summary of the prevalence estimates and methodological challenges presented by sleep disturbances in PTSD, highlights the recent evidence for empirically supported psychotherapeutic and pharmacological interventions for comorbid sleep disturbances implicated in PTSD, and provides a summary of recent findings on integrated and sequential treatment approaches to ameliorate comorbid sleep disturbances in PTSD.Recent findings: Insomnia, recurrent nightmares, and other sleep disorders are commonly endorsed among individuals with PTSD; however, several methodological challenges contribute to the varying prevalence estimates. Targeted sleep-focused therapeutic interventions can improve sleep symptoms and mitigate daytime PTSD symptoms. Recently, attention has focused on the role of integrated and sequential approaches, suggesting that comprehensively treating sleep disturbances in PTSD is likely to require novel treatment modalities.Summary: Evidence is growing on the development, course, and treatment of comorbid sleep disturbances in PTSD. Further, interventions targeting sleep disturbances in PTSD show promise in reducing symptoms. However, longitudinal investigations and additional rigorous controlled trials with diverse populations are needed to identify key features associated with treatment response in order to alleviate symptoms.","PeriodicalId":11088,"journal":{"name":"Current Treatment Options in Psychiatry","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2020-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1007/s40501-020-00222-y","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"25341564","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

引用次数: 4

Buprenorphine dosing for the treatment of opioid use disorder through pregnancy and postpartum. 治疗孕期和产后阿片类药物使用障碍的丁丙诺啡剂量。

Current Treatment Options in Psychiatry Pub Date : 2020-09-01 Epub Date: 2020-07-28 DOI: 10.1007/s40501-020-00221-z

Caitlin E Martin, Caroline Shadowen, Bhushan Thakkar, Travis Oakes, Tamas S Gal, F Gerard Moeller

{"title":"Buprenorphine dosing for the treatment of opioid use disorder through pregnancy and postpartum.","authors":"Caitlin E Martin, Caroline Shadowen, Bhushan Thakkar, Travis Oakes, Tamas S Gal, F Gerard Moeller","doi":"10.1007/s40501-020-00221-z","DOIUrl":"10.1007/s40501-020-00221-z","url":null,"abstract":"Purpose of review: Opioid-related deaths are a leading cause of mortality during pregnancy through 12 months postpartum. Buprenorphine use during pregnancy is increasing, yet expert opinion on its dosing through the perinatal period is limited. We provide a review of the current clinical literature on buprenorphine dosing during pregnancy through 12 months postpartum. and present data from a retrospective chart review of patients at our institution describing trends in buprenorphine dosing during pregnancy and postpartum. Utilizing this information, we synthesize findings to provide clinical recommendations for providers.Recent findings: Existing literature during pregnancy reflects how many women increase and split total daily buprenorphine doses as gestational age advances.Summary: We present data from a retrospective chart review of patients at our institution describing trends in buprenorphine dosing during pregnancy and postpartum. Utilizing this information, we synthesize findings to provide clinical recommendations for providers. Changes in the total daily dose of buprenorphine used across pregnancy and through 12 months postpartum at the individual level do not follow consistent patterns, highlighting substantial individual variability. Altogether, buprenorphine dosing should be individualized through pregnancy and postpartum with frequent evaluations by providers and solicited input from patients.","PeriodicalId":11088,"journal":{"name":"Current Treatment Options in Psychiatry","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2020-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7880143/pdf/nihms-1615513.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"25371895","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

引用次数: 0

Integrating Evidence-Based Guidelines on Pain and Opioids into Medical School Education 将疼痛和阿片类药物循证指南纳入医学院教育

Current Treatment Options in Psychiatry Pub Date : 2020-08-29 DOI: 10.1007/s40501-020-00218-8

Jean M. Bennett, Barbara Allison-Bryan

引用次数: 0

Prognostic Significance of Personality Disorders in Patients with Major Depressive Disorder 重度抑郁症患者人格障碍的预后意义

Current Treatment Options in Psychiatry Pub Date : 2020-08-28 DOI: 10.1007/s40501-020-00227-7

M. Young

引用次数: 1

Longitudinal Course of Borderline Personality Disorder: What Every Clinician Needs to Know 边缘型人格障碍的纵向病程:每个临床医生都需要知道的

Current Treatment Options in Psychiatry Pub Date : 2020-08-06 DOI: 10.1007/s40501-020-00223-x

L. Choi-Kain, S. Masland, E. A. Iliakis, Gabrielle S. Ilagan

引用次数: 3

Treating Depression in the Context of Mania or Mania Risk in Youth 在躁狂或躁狂风险的背景下治疗青少年抑郁症

Current Treatment Options in Psychiatry Pub Date : 2020-06-19 DOI: 10.1007/s40501-020-00225-9

Mandeep K. Kapur, Isheeta Zalpuri, Shelly Tran, Manpreet K. Singh

引用次数: 1

Harnessing the Healing Power of Relationships in Trauma Recovery: a Systematic Review of Cognitive-Behavioral Conjoint Therapy for PTSD 在创伤恢复中利用关系的治愈力：创伤后应激障碍认知行为联合治疗的系统综述

Current Treatment Options in Psychiatry Pub Date : 2020-06-10 DOI: 10.1007/s40501-020-00211-1

Rachel E. Liebman, Kristen M Whitfield, Iris Sijercic, Naomi Ennis, C. Monson

引用次数: 24

Psychotherapy for Borderline Personality Disorder: Does the Type of Treatment Make a Difference? 边缘型人格障碍的心理治疗:治疗类型有区别吗?

Current Treatment Options in Psychiatry Pub Date : 2020-06-10 DOI: 10.1007/s40501-020-00224-w

William D. Ellison

引用次数: 6

Advances in PTSD Treatment Delivery: Evidence Base and Future Directions for Intensive Outpatient Programs 创伤后应激障碍治疗递送的进展:强化门诊项目的证据基础和未来方向

Current Treatment Options in Psychiatry Pub Date : 2020-06-05 DOI: 10.1007/s40501-020-00219-7

K. Ragsdale, Laura E. Watkins, Andrew M. Sherrill, Liza C Zwiebach, B. Rothbaum

引用次数: 15

Simulation Methods as a Tool to Enhance Medical Student Education and Combat Stigma in Addictions 模拟方法作为加强医学生教育和打击成瘾污名的工具

Current Treatment Options in Psychiatry Pub Date : 2020-06-03 DOI: 10.1007/s40501-020-00220-0

L. Keyser-Marcus, Courtney M. Holmes, A. Adams, Cheryl Bodamer

引用次数: 0